Research Unit in Reproductive Medicine, Hospital de Ginecobstetricia Luis Castelazo Ayala, Instituto Mexicano del Seguro Social, Mexico, DF, Mexico.
Mol Cell Endocrinol. 2010 Jun 10;321(2):112-22. doi: 10.1016/j.mce.2010.02.027. Epub 2010 Mar 4.
Current evidence indicates that G protein-coupled receptors form dimers that may affect biogenesis and membrane targeting of the complexed receptors. We here analyzed whether expression-deficient follicle-stimulating hormone receptor (FSHR) mutants exert dominant negative actions on wild-type FSHR cell surface membrane expression. Co-transfection of constant amounts of wild-type receptor cDNA and increasing quantities of mutant (R556A or R618A) FSHR cDNAs progressively decreased agonist-stimulated cAMP accumulation, [(125)I]-FSH binding, and plasma membrane expression of the mature wild-type FSHR species. Co-transfection of wild-type FSHR fragments involving transmembrane domains 5-6, or transmembrane domain 7 and/or the carboxyl-terminus specifically rescued wild-type FSHR expression from the transdominant inhibition by the mutants. Mutant FSHRs also inhibited function of the luteinizing hormone receptor but not that of the thyrotropin receptor or non-related receptors. Defective intracellular transport and/or interference with proper maturation due to formation of misfolded mutant:wild-type receptor complexes may explain the negative effects provoked by the altered FSHRs.
目前的证据表明,G 蛋白偶联受体形成二聚体,这可能影响复合物受体的生物发生和膜靶向。我们在这里分析了表达缺陷的卵泡刺激素受体 (FSHR) 突变体是否对野生型 FSHR 细胞表面膜表达产生显性负效应。恒定数量的野生型受体 cDNA 和递增数量的突变体 (R556A 或 R618A) FSHR cDNA 的共转染逐渐降低了激动剂刺激的 cAMP 积累、[(125)I]-FSH 结合以及成熟野生型 FSHR 物种的质膜表达。涉及跨膜域 5-6 的野生型 FSHR 片段或跨膜域 7 和/或羧基末端的共转染特异性地从突变体的反显性抑制中挽救野生型 FSHR 表达。突变型 FSHRs 还抑制黄体生成素受体的功能,但不抑制促甲状腺素受体或非相关受体的功能。由于形成错误折叠的突变体:野生型受体复合物,可能导致缺陷的细胞内运输和/或对适当成熟的干扰,从而解释了改变的 FSHRs 引起的负面效应。